Oruni, Ambrose
Menze, Benjamin D.
Fotso-Toguem, Yvan G.
Ngannang-Fezeu, Vanessa B.
Thiomela, Riccado F.
Tchouakui, Magellan
Hearn, Jack
Kayondo, Jonathan
Wondji, Charles S.
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-006003)
Wellcome Trust (217188/Z/19/Z)
Article History
Received: 6 August 2025
Accepted: 29 December 2025
First Online: 2 January 2026
Declarations
:
: The authors declare no competing interests.
: The protocol to conduct this study was approved by The Uganda Virus Research Institute Research Ethics Committee (UVRI REC) (Ref: GC/127/833) and Uganda National Council for Science and Technology (UNCST) (HS2063ES). Prior to trials, written, informed and signed consents were obtained from the volunteers (sleepers). All the volunteers involved in the study were supervised, followed up and treated when showing signs and symptoms of malaria. All methods in this trial were performed in accordance with the relevant guidelines and regulations.
: All authors have consented to publication of this manuscript.